Cargando…
Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells
Hepatocellular carcinoma (HCC) is a complicated and poor prognosis cancer, necessitating the development of a potential treatment strategy. In this study, we initially revealed that LukS-PV belonged to leukocidin family performs an anti-HCC action. Then, we used liquid chromatography-mass spectromet...
Autores principales: | Zhao, Chang-Cheng, Yu, Wen-Wei, Qi, Ying-Jie, Xu, Liang-Fei, Wang, Zi-Ran, Qiang, Ya-Wen, Ma, Fan, Ma, Xiao-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028286/ https://www.ncbi.nlm.nih.gov/pubmed/31789624 http://dx.doi.org/10.1097/CAD.0000000000000866 |
Ejemplares similares
-
Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for Diagnostic and Therapeutic Applications
por: Okolie, Charles Emeka, et al.
Publicado: (2013) -
Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model
por: Karauzum, Hatice, et al.
Publicado: (2013) -
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
por: Wang, Ziran, et al.
Publicado: (2020) -
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
por: Wang, Ziran, et al.
Publicado: (2020) -
LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor
por: Zhang, Peng, et al.
Publicado: (2019)